BOUNDLESS BIO, INC.: cashflow_financing
| Value | {"amount": 89710000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-09-30 |
| Status | current |
| Entity | BOUNDLESS BIO, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:02:37.803141+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c383cb86-4bb8-43fc-a734-61b836de04a8
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-24-123291Retrieved: 2026-08-19T18:02:37.803141+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001782303/cashflow-financing/2024-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c383cb86-4bb8-43fc-a734-61b836de04a8
History
- no predecessors — first report